Academic Journal
Testicular diffuse large B-cell lymphoma. Clinical lecture and case report ; Диффузная крупноклеточная B-клеточная лимфома яичка. Клиническая лекция и наблюдение из практики
| العنوان: | Testicular diffuse large B-cell lymphoma. Clinical lecture and case report ; Диффузная крупноклеточная B-клеточная лимфома яичка. Клиническая лекция и наблюдение из практики |
|---|---|
| المؤلفون: | K. B. Lelyavin, A. V. Taranenko, V. G. Bryukhanov, К. Б. Лелявин, А. В. Тараненко, В. Г. Брюханов |
| المصدر: | Acta Biomedica Scientifica; Том 8, № 5 (2023); 81-91 ; 2587-9596 ; 2541-9420 |
| بيانات النشر: | Scientific Centre for Family Health and Human Reproduction Problems |
| سنة النشر: | 2023 |
| المجموعة: | Acta Biomedica Scientifica |
| مصطلحات موضوعية: | неходжкинская лимфома, primary testicular lymphoma, nonHodgkin lymphoma, первичная лимфома яичка |
| الوصف: | Lymphoma is a heterogeneous group of lymphocyte malignancies that may involve lymphatic tissue, bone marrow, or extranodal sites. The lecture provides a brief overview of the current state of the problem of diagnosis and treatment of primary testicular lymphoma. Primary testicular lymphoma (PTL) is a rare lymphoid malignancy. Though it is rare, PTL is the most common type of testicular tumor in men over 60 years of age. The most common histological type is diffuse large B-cell lymphoma. To date, there are no well-documented etiological or risk factors for PTL. In contrast to other common testicular neoplasms, there was no statistically significant association of PTL with cryptorchidism, trauma, chronic orchitis, or infertility. Ultrasound is generally the first-line imaging method used to characterize testicular lesions. PTL manifests itself in the form of a hypoechoic formation, which can take the form of either a single large formation or multiple small formations that occupy most of the testicular parenchyma or completely replace it. Systemic treatment, including orchiectomy, chemotherapy, radiation therapy, and intrathecal prophylaxis, is necessary for all patients with PTL. In addition to achieving complete remission, the goal of PTL treatment is to prevent recurrences in the contralateral testis and central nervous system. The presented information is supplemented by our own observation and images. Personal medical data is published with the written consent of the patient. In our case, the patient’s age was 38 years, which does not fall into the specified age group for primary testicular lymphoma. In our opinion, the publication of this clinical case and analysis of scientific literature on this topic are relevant. ; Лимфома представляет собой гетерогенную группу злокачественных новообразований лимфоцитов, которые могут вовлекать лимфатическую ткань, костный мозг или экстранодальные локализации. В лекции приводится краткий обзор современного состояния проблемы диагностики и лечения первичной лимфомы яичка. ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | Russian |
| Relation: | https://www.actabiomedica.ru/jour/article/view/4440/2655; Menter T, Ernst M, Drachneris J, Dirnhofer S, Barghorn A, Went P, et al. Phenotype profiling of primary testicular diffuse large B-cell lymphomas. Hematol Oncol. 2014; 32: 72-81. doi:10.1002/hon.2090; Казакевич В.И., Митина Л.А., Скрепцова Н.С., Востров А.Н., Майорова М.В., Прозорова Э.В., и др. Ультразвуковое исследование при лимфоме с поражением малого таза. Ультразвуковая и функциональная диагностика. 2015; 4S: 75-76.; Curling TB. A practical treatise on the diseases of testis and of the spermatic cord and scrotum. Philadelphia; 1856.; Malassez M. Lymphadenome du testicule, rapport sur la candidature de M. Letulle, interne des hospitaux au titre de member adjoint. Bull Soc Anta (Paris). 1877; 52: 176-178.; Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-Hodgkin’s lymphoma. Med Sci (Basel). 2021; 9(1): 5. doi:10.3390/medsci9010005; Lewis WD, Lilly S, Jones KL. Lymphoma: Diagnosis and treatment. Am Fam Physician. 2020; 101(1): 34-41.; Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20): 2375-2390. doi:10.1182/blood-2016-01-643569; Palumbo C, Mazzone E, Mistretta FA, Knipper S, Tian Z, Perrotte P, et al. Primary lymphomas of the genitourinary tract: A population-based study. Asian J Urol. 2020; 7(4): 332-339. doi:10.1016/j.ajur.2019.11.002; Ma RZ, Tian L, Tao LY, He HY, Li M, Lu M, et al. The survival and prognostic factors of primary testicular lymphoma: Two-decade single-center experience. Asian J Androl. 2018; 20(6): 615-620. doi:10.4103/aja.aja_73_18; Shahab N, Doll DC. Testicular lymphoma. Semin Oncol. 1999; 26: 259-269.; Тумян Г.С., Ковригина А.М., Тимофеева О.Л., Пробатова Н.А., Шолохова Е.Н., Тупицын Н.Н., и др. Особенности клинического течения и прогноз больных неходжкинской лимфомой с первичной локализацией в яичке. Современная онкология. 2006; 8(4): 22-26.; Ahmad SS, Idris SF, Follows GA, Williams MV. Primary testicular lymphoma. Clin Oncol (R Coll Radiol). 2012; 24(5): 358-365. doi:10.1016/j.clon.2012.02.005; Chen B, Cao DH, Lai L, Guo JB, Chen ZY, Huang Y, et al. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China. BMC Cancer. 2020; 20(1): 220. doi:10.1186/s12885-020-6711-0; Lemma SA, Kuusisto M, Haapasaari KM, Sormunen R, Lehtinen T, Klaavuniemi T, et al. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma. Carcinogenesis. 2017; 38(8): 812-820. doi:10.1093/carcin/bgx061; Roberts WC, Glancy DL, Devita VT. Heart in malignant lymphoma (Hodgkin’s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides): A study of 196 autopsy cases. Am J Cardiol. 1968; 22: 85-107. doi:10.1016/0002-9149(68)90250-6; Yasen Z, Kazzazi F, Ioannides K, Velmurugan S, Zegocki K, Li C. A case at crossroads-urological presentation, cardiac complication and haematological diagnosis: Should imaging be pursued prior to orchidectomy at all costs? J Surg Case Rep. 2021; 2021(5): rjab177. doi:10.1093/jscr/rjab177; Horne MJ, Adeniran AJ. Primary diffuse large B-cell lymphoma of the testis. Arch Pathol Lab Med. 2011; 135(10): 1363-1367. doi:10.5858/arpa.2010-0158-RS; Scott DW, Gascoyne RD. The tumor microenvironment in B cell lymphomas. Nat Rev Cancer. 2014; 14(8): 517-534. doi:10.1038/nrc3774; Moses K, Brandau S. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016; 28: 187-196. doi:10.1016/j.smim.2016.03.018; Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev. 2007; 18: 171-182. doi:10.1016/j.cytogfr.2007.01.015; Brandau S, Dumitru CA, Lang S. Protumor and antitumor functions of neutrophil granulocytes. Semin Immunopathol. 2013; 35: 163-176. doi:10.1007/s00281-012-0344-6; Leivonen SK, Pollari M, Brück O, Pellinen T, Autio M, Karjalainen-Lindsberg ML, et al. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma. Haematologica. 2019; 104(2): 338-346. doi:10.3324/haematol.2018.200105; Oishi N, Kondo T, Nakazawa T, Mochizuki K, Tanioka F, Oyama T, et al. High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses. Pathol Int. 2015; 65(10): 528-535. doi:10.1111/pin.12336; Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and pathogenesis of diffuse large B-cell ymphoma. N Engl J Med. 2018; 378(15): 1396-1407. doi:10.1056/NEJMoa1801445; Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019; 94(5): 604-616. doi:10.1002/ajh.25460; Mazzu D, Jeffrey RB Jr, Ralls PW. Lymphoma and leukemia involving the testicles: Findings on gray-scale and color Doppler sonography. AJR Am J Roentgenol. 1995; 164: 645-647. doi:10.2214/ajr.164.3.7863887; Benevolo G, Stacchini A, Spina M, Ferreri AJ, Arras M, et al. Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination. Blood. 2012; 120: 3222-3228. doi:10.1182/blood-2012-04-423095; Pollari M, Leivonen SK, Leppä S. Testicular diffuse large B-cell lymphoma-clinical, molecular, and immunological features. Cancers (Basel). 2021; 13(16): 4049. doi:10.3390/cancers13164049; Ballen KK, Hasserjian RP. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2004. A 31-year-old man with bilateral testicular enlargement. N Engl J Med. 2004; 350(20): 2081-2087. doi:10.1056/NEJMcpc049003; Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, et al. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: Final results of an international phase II trial. J Clin Oncol. 2011; 29(20): 2766-2772. doi:10.1200/JCO.2010.31.4187; Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: A population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol. 2009; 27(31): 5227-5232. doi:10.1200/JCO.2009.22.5896; Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, et al. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma-a survey of 1693 patients treated in protocols of the German high-grade non-Hodgkin’s lymphoma study group (DSHNHL). Ann Oncol. 2007; 18(1): 149-157. doi:10.1093/annonc/mdl327; Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: The impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol. 2010; 21(5): 1046-1052. doi:10.1093/annonc/mdp432; Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003; 21(1): 20-27. doi:10.1200/JCO.2003.11.141; Gundrum JD, Mathiason MA, Moore DB, Ronald SG. Primary testicular diffuse large B-cell lymphoma: A population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol. 2009; 27: 5227-5232. doi:10.1200/JCO.2009.22.5896; Mazloom A, Fowler N, Medeiros LJ, Iyengoar P, Horace P, et al. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: The M.D. Anderson Cancer Center experience. Leuk Lymphoma. 2010; 51: 1217-1224. doi:10.3109/10428191003793358; Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, et al. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: Results of a phase II Nordic Lymphoma Group study. Ann. Oncol. 2013; 24: 1385-1392. doi:10.1093/annonc/mds621; Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A. The SCARE 2020 guideline: Updating consensus Surgical CAse REport (SCARE) guidelines. Int J Surg. 2020; 84: 226-230. doi:10.1016/j.ijsu.2020.10.034; https://www.actabiomedica.ru/jour/article/view/4440 |
| DOI: | 10.29413/ABS.2023-8.5.8 |
| الاتاحة: | https://www.actabiomedica.ru/jour/article/view/4440 https://doi.org/10.29413/ABS.2023-8.5.8 |
| Rights: | Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |
| رقم الانضمام: | edsbas.98BF78B3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.29413/ABS.2023-8.5.8 |
|---|